Is sentinel node biopsy in melanoma a test or a treatment?BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f677 (Published 06 February 2013) Cite this as: BMJ 2013;346:f677
- Anthony J Dixon, professor1
- 1Australasian College of Cutaneous Oncology, Belmont, VIC 3216, Australia
Ten years ago we hoped sentinel lymph node biopsy (SNB) “treatment” would prolong life for patients with melanoma. Then the first Multicenter Selective Lymphadenectomy Trial (MSLT-1) failed to show a five year survival advantage.1 Now we talk of the SNB “test” offering some patients a more accurate survival prediction.
We advise …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial